Atrys Health, S.A.
ATRY
Rank in Stocks
#16049
Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in... Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in Madrid, Spain, specializes in providing a range of diagnostic services and medical treatments. Its diagnostic portfolio encompasses areas like pathology, hematology, molecular pathology, and genetics, supplemented by offerings such as diagnostic second opinions, a comprehensive test directory, and support for clinical trials and research & development. The company effectively utilizes telemedicine to deliver its expertise in medical specialties including radiology, cardiology, ophthalmology, and dermatology. Furthermore, Atrys Health administers radiotherapy and is engaged in the development of innovative therapeutic approaches and diagnostic instruments. The organization operated as Althia Health, S.L. before rebranding to Atrys Health, S.A. in May 2016.
Share Price
$3.04
Last synced: 2026-11-11
Market Cap
$230.56M
Change (1 day)
3.30%
Change (1 year)
-8.37%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Atrys Health, S.A. (ATRY)
Category
Healthcare
Operating Margin for Atrys Health, S.A. (ATRY)
Operating Margin as of November 2026 TTM: -9.79%
According to Atrys Health, S.A.'s latest financial reports, its current operating margin (TTM) is -9.79%. At the end of 2025 the company had an operating margin of -6.40%.
Operating Margin history for Atrys Health, S.A. from 2012 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -9.79% | 52.97% |
| 2025 | -6.40% | 29.03% |
| 2024 | -4.96% | 535.90% |
| 2023 | -0.78% | -82.27% |
| 2022 | -4.40% | -64.54% |
| 2021 | -12.41% | 1,725.00% |
| 2020 | -0.68% | -108.30% |
| 2019 | 8.19% | -22.44% |
| 2018 | 10.56% | 37.86% |
| 2017 | 7.66% | -3.89% |
| 2016 | 7.97% | 6.98% |
| 2015 | 7.45% | -82.08% |
| 2014 | 41.57% | -449.62% |
| 2013 | -11.89% | -261.33% |
| 2012 | 7.37% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 38.59% | -103.94% |
US
|
|
| -149.01% | -84.78% |
US
|
|
| 25.57% | -102.61% |
AU
|
|
| 31.23% | -103.19% |
BE
|
|
| 29.35% | -103.00% |
NL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Atrys Health, S.A.'s operating margin
What is Atrys Health, S.A.'s operating margin?
Atrys Health, S.A.'s operating margin is -9.79%, as of Nov 2026.
What was Atrys Health, S.A.'s operating margin in 2025?
In 2025, Atrys Health, S.A.'s operating margin was -6.40%, compared with -4.96% in 2024.
How has Atrys Health, S.A.'s operating margin changed since 2020?
From 2020 to 2025, Atrys Health, S.A.'s operating margin was highest in 2020 (-0.68%) and lowest in 2021 (-12.41%).
How does Atrys Health, S.A.'s operating margin compare with similar companies?
Atrys Health, S.A.'s operating margin (-9.79%) is higher than that of 1 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with 38.59%.